← Back to Search

Behavioral Intervention

Motivational Interviewing for HIV/AIDS and Alcohol Use

N/A

Recruiting

Led By Amy C Justice, MD, PhD

Research Sponsored by Yale University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline and 30 days post intervention

Awards & highlights

Study Summary

This trial aims to reduce bothersome symptoms of HIV patients who take 5+ meds & use alcohol. Alcohol can interact w/ medications and cause serious harm.

Who is the study for?

This trial is for HIV patients who are part of the VACS and MASH studies, take 5 or more medications, and have consumed alcohol in the last month. They must not have been diagnosed with a severe alcohol use disorder in the past year.Check my eligibility

What is being tested?

The HARP study tests a brief intervention combining Information-Motivation-Behavioral Skills (IMB) with motivational interviewing techniques to address symptoms affected by alcohol and medication interactions in HIV patients.See study design

What are the potential side effects?

While specific side effects aren't listed for this behavioral intervention, participants may experience discomfort discussing personal habits like medication use and alcohol consumption.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline and 30 days post intervention

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline and 30 days post intervention

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and 30 days post intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

HIV Vaccine

Body Weight Changes

Number of Medications Prescribed Post Intervention

Trial Design

1Treatment groups

Experimental Treatment

Group I: HIV Medications and Alcohol UseExperimental Treatment1 Intervention

Participants with HIV who take 5 or more medications and currently (within the past month) consume alcohol

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

National Institute on Alcohol Abuse and Alcoholism (NIAAA)NIH

802 Previous Clinical Trials

1,365,395 Total Patients Enrolled

425 Trials studying Alcoholism

985,868 Patients Enrolled for Alcoholism

Yale UniversityLead Sponsor

1,853 Previous Clinical Trials

2,738,511 Total Patients Enrolled

85 Trials studying Alcoholism

10,379 Patients Enrolled for Alcoholism

Amy C Justice, MD, PhDPrincipal InvestigatorYale University

Media Library

IMB-motivational interviewing (MI) techniques (IMB-MI) (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05560932 — N/A

Alcoholism Research Study Groups: HIV Medications and Alcohol Use

Alcoholism Clinical Trial 2023: IMB-motivational interviewing (MI) techniques (IMB-MI) Highlights & Side Effects. Trial Name: NCT05560932 — N/A

IMB-motivational interviewing (MI) techniques (IMB-MI) (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05560932 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any openings to join the research team at this time?

"As per the details on clinicaltrials.gov, this trial is currently enrolling patients. The study was initially published on March 6th 2023 and underwent its most recent amendment to data on March 7th of the same year."

Answered by AI

To what extent has enrollment been reached for this medical research?

"Yes, according to clinicaltrials.gov the trial is still recruiting patients which began on March 6th 2023 and was most recently updated on March 7th. At this time they are searching for 50 participants across 1 site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

HIV and Alcohol Research Center Focused on Polypharmacy (HARP)

2023. "HIV and Alcohol Research Center Focused on Polypharmacy (HARP)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05560932.